Showing 6701-6710 of 9115 results for "".
- Face Reality Skincare Partners with Olympic Swimming Medalist Abbey Weitzeilhttps://practicaldermatology.com/news/face-reality-skincare-partners-with-olympic-swimming-medalist-abbey-weitzeil/2460847/
- Mindera Platform Named MedTech’s “Best New Technology Solution for Dermatology"https://practicaldermatology.com/news/mindera-platform-named-medtechs-best-new-technology-solution-for-dermatology/2460799/
- New ASDS Guideline Addresses Prevention and Treatment of Filler Complicationshttps://practicaldermatology.com/news/new-asds-guideline-on-preventing-and-treating-filler-complications/2460685/The American Society for Dermatologic Surgery (ASDS) Multispecialty Soft-tissue Fillers Guideline Task Force has
- MyHealthTeams' "Gaining Control with Psoriasis" Challenge Empowers Psoriasis Patients to Change Things Uphttps://practicaldermatology.com/news/myhealthteams-gaining-control-with-psoriasis-challenge-empowers-psoriasis-patients-to-change-things-up/2460663/
- UCB, Stanford Medicine Partner to Seek New Ways to Treat HS, Other Diseaseshttps://practicaldermatology.com/news/ucb-stanford-medical-partner-to-seek-new-ways-to-treat-hs-other-diseases/2460613/UCB and
- Verrica's VP-102 has Positive Results in Phase 2 EWG Trialhttps://practicaldermatology.com/news/verricas-vp-102-has-positive-results-in-phase-2-ewg-trial/2460606/
- Remembering 9-11: A Dermatology Perspectivehttps://practicaldermatology.com/news/remembering-9-11-a-dermatology-perspective/2460522/New research takes a close look at dermatologic injuries and chronic skin conditions that have affected survivors and responders during the nearly two decades since the terrorist attacks on September 11, 2001. These chronic illnesses include sarcoidosis, autoimmune disease, ill-defined
- Medicine X Launches Eczema Xplained Patient Story To Drive Understanding and Awareness of ADhttps://practicaldermatology.com/news/medicine-x-launches-eczema-xplained-patient-story-to-drive-understanding-and-awareness-of-ad/2460519/Medicine X today is launching Eczema Xplained, its first illustrated story in the U.S. on atopic dermatitis, the most comm
- Arena Pharmaceuticals Announces First Subject Dosed in Phase 2 Trial Evaluating Etrasimod in Alopecia Areatahttps://practicaldermatology.com/news/arena-pharmaceuticals-announces-first-subject-dosed-in-phase-2-trial-evaluating-etrasimod-in-alopecia-areata/2460515/The first subject has been dosed in
- And the Winner Is...Dr. Junko Takeshita of University of Pennsylvania Wins 2020 Childhood Eczema Challenge Granthttps://practicaldermatology.com/news/and-the-winner-isdr-junko-takeshita-of-university-of-pennsylvania-wins-2020-childhood-eczema-challenge-grant/2460481/The